Chang Jin Wang
Fondatore presso FRONTIER BIOTECHNOLOGIES INC.
Patrimonio netto: 19 M $ in data 30/04/2024
Profilo
Chang Jin Wang is the founder of Frontier Biotechnologies, Inc. (China) since 2013, where he holds the title of General Manager & Director.
He previously held the position of Vice President-Business Development at VIVUS, Inc., Abmaxis, Inc., and TaiGen Biotechnology Co., Ltd.
from 2002 to 2006.
Dr. Wang holds a doctorate degree from the University of Kentucky and undergraduate and graduate degrees from West China University of Medical Sciences.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2022 | 21 059 500 ( 12.47% ) | 19 M $ | 30/04/2024 |
Posizioni attive di Chang Jin Wang
| Società | Posizione | Inizio |
|---|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Fondatore | 15/01/2013 |
Precedenti posizioni note di Chang Jin Wang
| Società | Posizione | Fine |
|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Corporate Officer/Principal | 01/07/2006 |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 01/05/2004 |
| VIVUS, INC. | Corporate Officer/Principal | - |
Formazione di Chang Jin Wang
| University of Kentucky | Doctorate Degree |
| West China University of Medical Sciences | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Health Technology |
| Aziende private | 3 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Chang Jin Wang